Boo Su-Lyn Profile picture
Jun 24, 2021 6 tweets 3 min read Read on X
Nearly 14% Of Covid-19 Fatalities This Year Were Healthy

This year saw a gradual increase of Covid-19 fatalities without comorbidities in Malaysia, reaching about 16% in June up to June 19.

codeblue.galencentre.org/2021/06/24/nea…
527 people without comorbidities died from Covid-19 in Malaysia this year up to June 19, or about 14% of 3,877 total fatalities.

May and the first 19 days of June saw a steep increase in Covid deaths at 1,290 and 1,552 fatalities respectively, along with non-comorbid deaths. Image
Of the 527 people without underlying health conditions who died from Covid-19 this year up to June 19, nearly 85% were Malaysians. Image
The highest rate of Covid-19 deaths without comorbidities this year up to June 19:
- Labuan (261 deaths per million population)
- KL (43)
- Melaka (26)
- Selangor (25)
- Negeri Sembilan (20) Image
The highest proportion of Covid-19 deaths without comorbidities this year (up to June 19) was among those aged 15-24 at 31%, or 4 of 13 total fatalities.

More Covid-19 fatalities w/o comorbidities, however, were recorded at 103 and 244 deaths in the 55-64 and ≥65 respectively. Image
The highest proportion of Covid brought-in-dead without comorbidities was reported in the 15-24 age group at 15%, or 2 of 13 total deaths.

But higher numbers of BID w/o comorbidities were recorded among people aged ≥65 years at 52 deaths, followed by 45-54 age grp (41 deaths). Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Boo Su-Lyn

Boo Su-Lyn Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @boosulyn

Jun 5, 2022
Malaysia's current medicine shortage isn't like previous "minor" perennial drug shortages, when certain meds tend to run out towards end of the year because of low funding.

This time, the med shortage may be far more critical & extensive because of global supply disruptions. 🧵
Malaysia is a net pharmaceutical importer.

This makes us extremely vulnerable to global supply disruptions caused by Covid pandemic, worsened by China lockdowns in 2022, and the Russia-Ukraine war that disrupted global supply chains across goods (not just pharmaceuticals).
Malaysia's entire supply of finished pharmaceutical products is either:

a) Directly imported
b) Indirectly imported via import of active pharmaceutical ingredients [APIs] (the active component of a drug), plus pharmaceutical intermediates and excipients (other components)
Read 24 tweets
Apr 4, 2022
I'm quite disgusted with the MySejahtera affair and attempted shortcuts to profit from a Covid app.

38 mil users were FORCED to download MySejahtera.

I get it, business is business and the govt monumentally screwed up by not creating a contract -- but this is all so unethical.
This isn't like Grab when we voluntarily downloaded the app, even though Grab is now a 🇸🇬 company.

Or like Facebook, which we still use despite multiple data privacy scandals.

Taking advantage of a huge database created from a govt mandate for a pandemic is simply perverse.
If you want to become the next tech unicorn, persuade people to use your app.

Create a great product that improves our daily lives -- not abuse a govt mandate.

The State has only so much power. You still need ppl to ❤️ your product.

Now, I hate MySejahtera more than ever.
Read 5 tweets
Apr 4, 2022
Agreements disclosed in a second lawsuit involving MySJ Sdn Bhd -- board power struggle -- show that MySJ owns the MySejahtera app, IP rights, and platform, while Entomo owns software used to develop the app.

MySJ targets future listing as tech company.

codeblue.galencentre.org/2022/04/04/mor…
Aug 2021 share sale agreement states MySJ is negotiating to acquire a health care management services company and a digital health care platform services company.

Mudah Healthcare & AmanInsure named in meeting minutes.

Both located in same address next to Entomo/MySJ's office.
AmanInsure Sdn Bhd's site even has mock-ups of MySejahtera with Covid-19 insurance/ takaful button (which scared me initially because AmanInsure didn't call it "mock-ups", but called it "User Journey).

Govt claims MySejahtera app/ IP ownership, but a private company can do this.
Read 13 tweets
Apr 2, 2022
How @codebluenews broke the MySejahtera controversy: 🧵

PAC tabled its 2nd Covid vaccine procurement report on March 24. My colleague @alifahzndn spotted it in the Order Paper.

(CodeBlue checks Parliament order papers and replies to spot any bills/ answers related to health).
At that time, PAC chair @wongkahwoh didn't issue a statement about the release of PAC's Covid vaccine procurement report (should be done for reports in future).

Link to the report here:
parlimen.gov.my/pac/review/doc…

On PAC's site, it's under Laporan => Tindakan Susulan Kementerian.
I also suspect that no one at the March 8, 2022 PAC meeting fully understood the enormity of the MOF/ MOH officials' testimonies at that time.

And the meeting seemed to kinda end casually.

Which perhaps explains why PAC didn't issue a statement about MySejahtera then.
Read 19 tweets
Feb 10, 2022
This Pharmaniaga statement -- which MOH's ICR denounced as having "misrepresented" facts and evidence -- failed to mention that the Yale study did NOT compare Sinovac vs Pfizer boosters and that two Sinovac doses showed no "detectable" neutralizing antibodies against Omicron.
A Pfizer booster did elicit "detectable" neutralization against Omicron for double-vax Sinovac recipients, but only increased protection to similar levels as 2 Pfizer jabs.

In other words, 2 Sinovac + 1 Pfizer = 2 Pfizer.

NOT that a Sinovac booster is better than Pfizer booster
Hence why one of the authors of the Yale-Dominican Republic study suggested that Sinovac recipients may need two boosters to protect against Omicron, instead of one.

Because 1 Pfizer booster + 2 Sinovac doses only raises protection to 2 mRNA doses.

Read 16 tweets
Feb 10, 2022
This is the proper context for the Yale-Dominican Republic study that looked at effectiveness of Pfizer booster for Sinovac recipients.

Two Sinovac doses showed NO protection against Omicron, and a Pfizer booster only increased protection to the same level as two Pfizer jabs.
It is extremely deceptive to give the impression that a Pfizer booster for Sinovac recipients is less effective against Omicron and to put up another completely unrelated study to imply that a Sinovac booster is better than a Pfizer booster for Sinovac recipients.
If you want to talk about a research study on Sinovac alone, then don't headline your statement on another completely unrelated study.

Btw no company in the life sciences puts down another company's products.

Independent researchers make the comparison.
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(